Duration of thyroid dysfunction correlates with all-cause mortality. The OPENTHYRO register cohort

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Laulund, Anne Sofie ^a   Nybo, Mads ^a   Brix, Thomas Heiberg ^a   Abrahamsen, Bo ^b,c,d   Jørgensen, Henrik Løvendahl ^e   Hegedüs, Laszlo ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c Institute of Clinical Research   (Denmark)

^d GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^e BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; AGE DISTRIBUTION; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DENMARK; FEMALE; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHENOTYPE; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; THYROID DISEASE; THYROTROPIN BLOOD LEVEL; BLOOD; COHORT ANALYSIS; EPIDEMIOLOGY; HYPOTHYROIDISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; REGISTER; THYROID DISEASES; THYROID GLAND; TIME;

COHORT STUDIES; DENMARK; FEMALE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; THYROID DISEASES; THYROID GLAND; THYROTROPIN; TIME FACTORS;

EID: 84908431956     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110437     Document Type: Article

References (62)

1. Brown-Borg HM (2007) Hormonal regulation of longevity in mammals. Ageing Res Rev 6: 28-45.
2. Osman F, Franklyn JA, Holder R.L., Sheppard MC, Gammage MD (2007) Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study. J Am Coll Cardiol 49: 71-81.
3. Flynn RW, Macdonald TM, Jung R.T., Morris AD, Leese GP (2006) Mortality and vascular outcomes in patients treated for thyroid dysfunction. J Clin Endocrinol Metab 91: 2159-2164.
4. Brandt F, Thvilum M, Almind D., Christensen K, Green A, et al. (2013) Morbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study. PLoS One 8: e66711.
5. Nyirenda MJ, Clark DN, Finlayson A.R., Read J., Elders A, et al. (2005) Thyroid disease and increased cardiovascular risk. Thyroid 15: 718-724.
6. Goldman MB, Monson RR, Maloof F (1990) Cancer mortality in women with thyroid disease. Cancer Res 50: 2283-2289.
7. Milla CE, Zirbes J (2012) Pulmonary complications of endocrine and metabolic disorders. Paediatr Respir Rev 13: 23-28.
8. Thvilum M, Brandt F, Almind D., Christensen K, Brix TH, et al. (2014) Increased Psychiatric Morbidity Before and After the Diagnosis of Hypothy-roidism: A Nationwide Register Study. Thyroid. In press.
9. Brandt F, Thvilum M, Almind D., Christensen K, Green A, et al. (2014) Hyperthyroidism and psychiatric morbidity: evidence from a Danish nationwide register study. Eur J Endocrinol 170: 341-348.
10. Ochs N, Auer R, Bauer D.C., Nanchen D., Gussekloo J, et al. (2008) Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med 148: 832-845.
11. Thvilum M, Brandt F, Brix T.H., Hegedus L (2012) A review of the evidence for and against increased mortality in hypothyroidism. Nat Rev Endocrinol 8: 417-424.
12. Brandt F, Green A, Hegedus L., Brix TH (2011) A critical review and meta-analysis of the association between overt hyperthyroidism and mortality. Eur J Endocrinol 165: 491-497.
13. Bauer DC, Rodondi N, Stone K.L., Hillier TA, Study of Osteoporotic Fractures Research Group: Universities of California PM, et al. (2007) Thyroid hormone use, hyperthyroidism and mortality in older women. Am J Med 120: 343-349.
14. Singh S, Duggal J, Molnar J., Maldonado F, Barsano CP, et al. (2008) Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. Int J Cardiol 125: 41-48.
15. Yang LB, Jiang DQ, Qi W.B., Zhang T., Feng YL, et al. (2012) Subclinical hyperthyroidism and the risk of cardiovascular events and all-cause mortality: an updated meta-analysis of cohort studies. Eur J Endocrinol 167: 75-84.
16. Thvilum M, Brandt F, Almind D., Christensen K, Hegedus L, et al. (2013) Excess mortality in patients diagnosed with hypothyroidism: a nationwide cohort study of singletons and twins. J Clin Endocrinol Metab 98: 1069-1075.
17. Brandt F, Almind D, Christensen K., Green A, Brix TH, et al. (2012) Excess mortality in hyperthyroidism: the influence of preexisting comorbidity and genetic confounding: a danish nationwide register-based cohort study of twins and singletons. J Clin Endocrinol Metab 97: 4123-4129.
18. Pedersen CB (2011) The Danish Civil Registration System. Scand J Public Health 39: 22-25.
19. Sortso C, Thygesen LC, Bronnum-Hansen H (2011) Database on Danish population-based registers for public health and welfare research. Scand J Public Health 39: 17-19.
20. Thygesen LC, Ersboll AK (2011) Danish population-based registers for public health and health-related welfare research: introduction to the supplement. Scand J Public Health 39: 8-10.
21. Thygesen LC, Daasnes C, Thaulow I., Bronnum-Hansen H (2011) Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand J Public Health 39: 12-16.
22. Johannesdottir SA, Horvath-Puho E, Ehrenstein V., Schmidt M, Pedersen L, et al. (2012) Existing data sources for clinical epidemiology: The Danish National Database of Reimbursed Prescriptions. Clin Epidemiol 4: 303-313.
23. Jensen E, Hyltoft Petersen P, Blaabjerg O, Hansen P.S., Brix TH, et al. (2004) Establishment of a serum thyroid stimulating hormone (TSH) reference interval in healthy adults. The importance of environmental factors, including thyroid antibodies. Clin Chem Lab Med 42: 824-832.
24. Charlson ME, Pompei P, Ales K.L., MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383.
25. Metso S, Jaatinen P, Huhtala H., Auvinen A, Oksala H, et al. (2007) Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthy-roidism. J Clin Endocrinol Metab 92: 2190-2196.
26. Hall P, Lundell G, Holm LE (1993) Mortality in patients treated for hyperthyroidism with iodine-131. Acta Endocrinol (Copenh) 128: 230-234.
27. Franklyn JA, Maisonneuve P, Sheppard M.C., Betteridge J., Boyle P (1998) Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med 338: 712-718.
28. Volzke H, Schwahn C, Wallaschofski H., Dorr M (2007) Review: The association of thyroid dysfunction with all-cause and circulatory mortality: is there a causal relationship? J Clin Endocrinol Metab 92: 2421-2429.
29. Haentjens P, Van Meerhaeghe A, Poppe K, Velkeniers B (2008) Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. Eur J Endo-crinol 159: 329-341.
30. Collet TH, Gussekloo J, Bauer D.C., den Elzen WP, Cappola AR, et al. (2012) Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 172: 799-809.
31. Surks MI, Ortiz E, Daniels G.H., Sawin CT, Col NF, et al. (2004) Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291: 228-238.
32. Biondi B, Cooper DS (2008) The clinical significance of subclinical thyroid dysfunction. Endocr Rev 29: 76-131.
33. Biondi B, Palmieri EA, Lombardi G, Fazio S (2002) Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 137: 904-914.
34. Biondi B (2012) Mechanisms in endocrinology: Heart failure and thyroid dysfunction. Eur J Endocrinol 167: 609-618.
35. Coceani M, Iervasi G, Pingitore A., Carpeggiani C, L'Abbate A (2009) Thyroid hormone and coronary artery disease: from clinical correlations to prognostic implications. Clin Cardiol 32: 380-385.
36. Mingote E, Merono T, Rujelman R., Marquez A, Fossati P, et al. (2012) High TSH and low T4 as prognostic markers in older patients. Hormones (Athens) 11: 350-355.
37. Iglesias P, Ridruejo E, Munoz A., Prado F, Macias MC, et al. (2013) Thyroid function tests and mortality in aged hospitalized patients: a 7-year prospective observational study. J Clin Endocrinol Metab 98: 4683-4690.
38. Maldonado LS, Murata GH, Hershman J.M., Braunstein GD (1992) Do thyroid function tests independently predict survival in the critically ill? Thyroid 2: 119-123.
39. McQuade C, Skugor M, Brennan D.M., Hoar B., Stevenson C, et al. (2011) Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database study. Thyroid 21: 837-843.
40. Petersen K, Bengtsson C, Lapidus L., Lindstedt G, Nystrom E (1990) Morbidity, mortality, and quality of life for patients treated with levothyroxine. Arch Intern Med 150: 2077-2081.
41. Radacsi A, Kovacs G, Bernard W., Feldkamp J, Horster FA, et al. (2003) Mortality rate of chronically ill geriatric patients with subnormal serum thyrotropin concentration: a 2-yr follow-up study. Endocrine 21: 133-136.
42. Cappola AR, Fried LP, Arnold A.M., Danese MD, Kuller LH, et al. (2006) Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295: 1033-1041.
43. Alevizaki M, Synetou M, Xynos K., Alevizaki CC, Vemmos KN (2006) Hypothyroidism as a protective factor in acute stroke patients. Clin Endocrinol (Oxf) 65: 369-372.
44. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich M, et al. (2004) Thyroid status, disability and cognitive function, and survival in old age. JAMA 292: 2591-2599.
45. McGue M, Osler M, Christensen K (2010) Causal Inference and Observational Research: The Utility of Twins. Perspect Psychol Sci 5: 546-556.
46. Rodondi N, Newman AB, Vittinghoff E, de Rekeneire N, Satterfield S, et al. (2005) Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 165: 2460-2466.
47. Klein I, Danzi S (2007) Thyroid disease and the heart. Circulation 116: 1725-1735.
48. Parle JV, Maisonneuve P, Sheppard M.C., Boyle P., Franklyn JA (2001) Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358: 861-865.
49. Vanderpump MP, Tunbridge WM, French J.M., Appleton D., Bates D, et al. (1996) The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid 6: 155-160.
50. Slag MF, Morley JE, Elson M.K., Crowson TW, Nuttall FQ, et al. (1981) Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA 245: 43-45.
51. Iglesias P, Munoz A, Prado F., Guerrero MT, Macias MC, et al. (2009) Alterations in thyroid function tests in aged hospitalized patients: prevalence, aetiology and clinical outcome. Clin Endocrinol (Oxf) 70: 961-967.
52. Franklyn JA (1999) Thyroid disease and its treatment: short- and long-term consequences. J R Coll Physicians Lond 33: 564-567.
53. Osman F, Gammage MD, Franklyn JA (2001) Thyroid disease and its treatment: short-term and long-term cardiovascular consequences. Curr Opin Pharmacol 1: 626-631.
54. van den Beld AW, Visser TJ, Feelders R.A., Grobbee DE, Lamberts SW (2005) Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. J Clin Endocrinol Metab 90: 6403-6409.
55. Hegedus L, Rasmussen N, Ravn V., Kastrup J, Krogsgaard K, et al. (1988) Independent effects of liver disease and chronic alcoholism on thyroid function and size: the possibility of a toxic effect of alcohol on the thyroid gland. Metabolism 37: 229-233.
56. Brix TH, Hansen PS, Kyvik K.O., Hegedus L (2000) Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case-control study. Arch Intern Med 160: 661-666.
57. Solanki A, Bansal S, Jindal S., Saxena V, Shukla US (2013) Relationship of serum thyroid stimulating hormone with body mass index in healthy adults. Indian J Endocrinol Metab 17: S167-169.
58. Stoving RK, Bennedbaek FN, Hegedus L, Hagen C (2001) Evidence of diffuse atrophy of the thyroid gland in patients with anorexia nervosa. Int J Eat Disord 29: 230-235.
59. Ceresini G, Lauretani F, Maggio M., Ceda GP, Morganti S, et al. (2009) Thyroid function abnormalities and cognitive impairment in elderly people: results of the Invecchiare in Chianti study. J Am Geriatr Soc 57: 89-93.
60. Laurberg P, Pedersen KM, Vestergaard H, Sigurdsson G (1991) High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. J Intern Med 229: 415-420.
61. Laurberg P, Cerqueira C, Ovesen L., Rasmussen LB, Perrild H, et al. (2010) Iodine intake as a determinant of thyroid disorders in populations. Best Pract Res Clin Endocrinol Metab 24: 13-27.
62. Brandt F, Thvilum M, Almind D., Christensen K, Green A, et al. (2013) Graves' disease and toxic nodular goiter are both associated with increased mortality but differ with respect to the cause of death: a Danish population-based register study. Thyroid 23: 408-413.